Can Cannabis Use Exacerbate Mental Illnesses Like Schizophrenia?

Yes. Cannabis containing THC can worsen psychotic symptoms and is associated with relapse in people with schizophrenia. A product marketed as balanced or CBD-rich should not be assumed to prevent that risk. New hallucinations, severe paranoia or disorganized thinking after cannabis use deserve prompt assessment rather than reassurance that they will necessarily disappear with the high.

Psychosis and Schizophrenia Are Not the Same Thing

Psychosis describes symptoms involving a loss of contact with reality, such as hallucinations or delusions. It can occur in several conditions, including schizophrenia, mood disorders and substance-related illness. An episode after cannabis use does not by itself establish a schizophrenia diagnosis.

Schizophrenia can involve psychotic symptoms, disorganized thinking, cognitive difficulties and reduced motivation or emotional expression. Assessment considers the person’s history and course of symptoms. Recovery-oriented treatment and support can help people manage symptoms and pursue their goals.

What Cannabis Research Shows

THC causes cannabis intoxication and can produce anxiety, paranoia and psychotic symptoms. The CDC notes an association between cannabis use and schizophrenia that is stronger with earlier initiation and more frequent use.

Schizophrenia has multiple contributing factors. Observational associations cannot prove that cannabis caused an individual person’s illness, and not everyone who uses cannabis develops psychosis. That uncertainty does not make continued use harmless for someone who has already experienced psychotic symptoms.

In a 2023 analysis from the OPTIMISE study, cannabis use after remission from a first episode of schizophrenia-spectrum illness was associated with an approximately threefold higher hazard of relapse. The association remained among patients who adhered to antipsychotic medication. Cannabis use preceded later worsening, rather than simply appearing after relapse.

This was an analysis of a particular clinical population, not a prediction of an individual’s absolute risk. It supports discussing cannabis directly as part of relapse prevention, even when medication adherence is good.

CBD Does Not Reliably Protect Against THC

CBD does not produce the same high as THC, but that does not make a THC/CBD mixture a safe choice for schizophrenia.

A 2025 randomized crossover trial studied 30 people with schizophrenia or schizoaffective disorder and cannabis use disorder. They received 1,000 mg oral CBD or placebo before inhaling cannabis containing THC. CBD did not reduce the adverse effects: delayed verbal recall was worse, and positive psychotic symptoms increased more after CBD pretreatment.

The study tested a specific high-dose pretreatment protocol and does not establish what happens with every formulation. It does directly challenge the idea that adding CBD can be relied on to protect someone with schizophrenia while they use THC.

CBD as a Treatment Remains Experimental

Research on pharmaceutical CBD as a treatment is a separate question from whether CBD makes cannabis safer. A 2026 meta-analysis of eight trials found no greater overall clinical effectiveness than placebo or the antipsychotic comparator amisulpride.

Another 2026 review of five trials of add-on CBD found small improvements in total and positive symptoms, but no significant improvement in negative symptoms. The authors called for larger trials to clarify clinical importance.

These reviews used different inclusion criteria and comparisons. Together, they leave uncertainty about benefit; they do not justify replacing antipsychotic medication with a retail CBD oil or trying to reproduce research doses independently.

Practical Steps for Patients and Families

Tell the treating clinician about cannabis use, including frequency, product type and THC amounts when known. Explain any change in sleep, suspiciousness, voices, concentration or functioning. A personal or family history of psychosis makes this discussion especially important.

For someone whose psychosis is worsened by cannabis, the goal should be support to stop use rather than reassurance based on a product ratio. If stopping is difficult, ask for treatment that addresses both the mental health condition and substance use. Do not stop prescribed medication on your own.

NIMH describes coordinated specialty care for early psychosis as a combination of medication management, therapy, family support and help with work or education. Seeking care early can improve the chances of recovery.

When to Seek Urgent Help

New or worsening hallucinations, severe paranoia, confusion or inability to care for basic needs warrant urgent professional assessment. Stay with the person if it is safe, speak calmly and help them access care.

In the United States, call or text 988 for crisis support. Call 911 when there is immediate danger or a life-threatening emergency. Elsewhere, use your local crisis or emergency service. Avoid assuming that a serious episode needs only time to wear off.